FATE Q3 Earnings Beat on Higher Revenues, Pipeline in Focus [Yahoo! Finance]
Immunocore Holdings plc (NASDAQ: IMCR) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $38.00 price target on the stock, down previously from $72.00.
The Galien Foundation Honors 2024 Prix Galien Award Recipients
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc (NASDAQ: IMCR) had its price target lowered by analysts at Needham & Company LLC from $78.00 to $71.00. They now have a "buy" rating on the stock.